期刊文献+

序联灌注预防膀胱癌术后复发的临床观察 被引量:8

Sequential intravesical instillations for the prevention of bladder cancer recurrence after surgical management
原文传递
导出
摘要 为了解顺序联合膀胱灌注预防膀胱癌术后复发的疗效,自1991年6月~1997年2月,用噻替哌60mg、卡铂400mg、阿霉素40mg加异博定10mg顺序联合膀胱灌注膀胱癌患者68例,每周一种药物共6周,以后每个月一种药物持续至术后2年,随访10个月~5年5个月,平均3年5个月。结果T1和T2肿瘤者无1例复发,副作用轻。结果表明,多药序联膀胱灌注疗效优于单药灌注。 For the prevention of tumor recurrence, from June 1991 to Feb. 1997, sequential intravesical instillation of adriamycin(40mg) and verapamil (10mg) combined with thioTEPA(60mg),carboplatin (400mg) was carried out for 68 cases of bladder carcinoma after surgery. The average follow up period was 3 years and five months. No recurrence has been observed in all the 62 cases of stage T1 and T2 tumors. Side effects were mild. It might be an effective means of preventing drug resistance and recurrence of bladder tumor.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 1997年第12期735-735,共1页 Chinese Journal of Urology
关键词 膀胱肿瘤 预防 复发 序联灌注 Bladder neoplasms Carcinoma Perfusion
  • 相关文献

参考文献2

  • 1顾方六,泌尿外科,1993年,464页
  • 2韩锐,肿瘤化学预防及药物治疗,1991年,258,284页

同被引文献38

  • 1余志贤,翁志梁,吴秀玲,陈韶,李澄棣,薛兆英.聚维酮联合阿霉素膀胱灌注预防浅表膀胱癌复发的应用研究[J].中华泌尿外科杂志,2004,25(8):560-561. 被引量:12
  • 2吴荣扬,詹炳炎,王玲珑,张孝斌,吴漾光,万瑞钦,彭善友.膀胱粘膜下注射抗癌药物的实验研究与临床观察[J].中华泌尿外科杂志,1993,14(2):108-110. 被引量:40
  • 3苟欣,肖明朝,何梓铭.BCG和IL-2膀胱灌注预防膀胱癌复发的疗效观察[J].中华泌尿外科杂志,1996,17(2):91-93. 被引量:15
  • 4周荣祥.膀胱外科[M].北京:人民卫生出版社,1995..
  • 5Toma C,John MF.Bladder cancer[M].In Robert JS,Mike BS,John MF,eds.Clinical Urology.JB Lippncott Company Philadephia,1994:637-44.
  • 6Belldegrun AS,Franklin JR,O'Donnell MA,et al.Superficial bladder cancer:the role of interferon-α[M].J Urol,1998,159:1793-801.
  • 7Sekine H,Fukui I,Yamada T,et al.Intravesical mitomycin C and doxorubicin sequential therapy for carcinoma in situ of the bladder:A longer followup result[J].J Urol,1994,151:27-30.
  • 8Seraphim LA,Perrapato SD,Slocum HR.In vitro study of the interaction of doxorubicin,thiotepa and mitomycin C agents used for intravesical chemotherapy of superficial bladder cancer[J].J Urol,1991,145:613-7.
  • 9Okamoto E,Kinne R.K.H,Sokeland J.Interferons modify in vitro proliferation of human bladder transitional cell carcinoma in the presence of doxorubicin and mitomycin C[J].J Urol,1996,156:1492-5.
  • 10Uekado Y,Hirano A,Shinka T,et al.The effects of intravesical chemoimmunotherapy with epirubicin and bacillus calmette-guerin for prophylaxis of recurrence of superficial bladder cancer:a preliminary report[J].Cancer Chemother Pharmacol,1994,35:65-8.

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部